Institution
Guy's and St Thomas' NHS Foundation Trust
Healthcare•London, United Kingdom•
About: Guy's and St Thomas' NHS Foundation Trust is a healthcare organization based out in London, United Kingdom. It is known for research contribution in the topics: Population & Randomized controlled trial. The organization has 7686 authors who have published 9631 publications receiving 399353 citations. The organization is also known as: Guy's and St Thomas' National Health Service Foundation Trust & Guy's and St Thomas' National Health Service Trust.
Papers published on a yearly basis
Papers
More filters
••
Great Ormond Street Hospital for Children NHS Foundation Trust1, Guy's and St Thomas' NHS Foundation Trust2, Royal Children's Hospital3, Paracelsus Private Medical University of Salzburg4, Vanderbilt University5, University of Massachusetts Medical School6, Cincinnati Children's Hospital Medical Center7, University of New South Wales8, Clínica Alemana9, University of Monterrey10, King's College London11
TL;DR: New guidelines on the diagnosis and management of cutaneous squamous cell carcinomas in people with epidermolysis bullosa are presented to help inform decision making by clinicians dealing with this complex complication of a devastating disease.
Abstract: This article summarizes recommendations reached following a systematic literature review and expert consensus on the diagnosis and management of cutaneous squamous cell carcinomas in people with epidermolysis bullosa. The guidelines are intended to help inform decision making by clinicians dealing with this complex complication of a devastating disease.
96 citations
••
TL;DR: Although it was feasible to deliver the intervention in this setting, it took longer to complete than anticipated, and this intervention may be a way of enhancing the end-of-life experiences of residents.
Abstract: Background:A pilot study of Dignity Therapy conducted with hospice patients reported high levels of self-reported benefits of the psychotherapy.Aim:To assess the feasibility, acceptability and potential effectiveness of Dignity Therapy to reduce distress in older people in care homes.Design:A randomized controlled open-label trial (ISRCTN37589515). Setting and participants: 60 residents aged 65+ with no major cognitive impairment living in care homes in London, UK.Intervention:Dignity Therapy, a brief palliative care psychotherapy.Outcomes:Potential effectiveness (dignity-related distress, depression, hopefulness, quality of life at baseline and 1 and 8-week follow-up); acceptability (residents’ views on self-reported benefits of Dignity Therapy/the Dignity Therapy study); and feasibility (time taken to deliver the intervention).Results:We randomized 60/755 (8%) residents: 29 – control, 31 – intervention. We found no significant differences between groups on measures of potential effectiveness at any time...
96 citations
••
TL;DR: Venous thrombosis is common in patients with severe COVID-19 pneumonia and many of these thromBoses may be immunothromboses due to local inflammation, rather than thromboembolic disease.
96 citations
••
TL;DR: The long-standing debate regarding how social communication/pragmatic impairments overlap and/or differ from language impairments, ASD, and other neurodevelopmental disorders is examined.
Abstract: Social (pragmatic) communication disorder (SCD) is a new diagnostic category in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). The purpose of this review is to describe and synthesize the relevant literature from language and autism spectrum disorder (ASD) research relating to pragmatic language impairment and other previously used terms that relate to SCD. The long-standing debate regarding how social communication/pragmatic impairments overlap and/or differ from language impairments, ASD, and other neurodevelopmental disorders is examined. The possible impact of the addition of SCD diagnostic category and directions for future research are also discussed.
96 citations
••
TL;DR: This poster presents a poster presented at the 2016 British Association for the Advance Study of Oncology and Haematology Congress (BAS) to discuss the science and practice of cell reprograming and its applications in medicine and cancer.
Abstract: National Amyloidosis Centre, Division of Medicine, UCL, London Department of Haematology, Bristol Haematology and Oncology Centre, Bristol Department of Haematology, St Bartholomew's Hospital, London Department of Haematology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool Departments of Oncology and Haematology, Guy's & St Thomas' NHS Foundation Trust, London Department of Haematology, Birmingham Heartlands Hospital and School of Cancer Sciences, University of Birmingham, Birmingham
96 citations
Authors
Showing all 7765 results
Name | H-index | Papers | Citations |
---|---|---|---|
Christopher J L Murray | 209 | 754 | 310329 |
Bruce M. Psaty | 181 | 1205 | 138244 |
Giuseppe Remuzzi | 172 | 1226 | 160440 |
Mika Kivimäki | 166 | 1515 | 141468 |
Simon I. Hay | 165 | 557 | 153307 |
Theo Vos | 156 | 502 | 186409 |
Ali H. Mokdad | 156 | 634 | 160599 |
Steven Williams | 144 | 1375 | 86712 |
Igor Rudan | 142 | 658 | 103659 |
Mohsen Naghavi | 139 | 381 | 169048 |
Christopher D.M. Fletcher | 138 | 674 | 82484 |
Martin McKee | 138 | 1732 | 125972 |
David A. Jackson | 136 | 1095 | 68352 |
Graham G. Giles | 136 | 1249 | 80038 |
Yang Liu | 129 | 2506 | 122380 |